Chronic liver disease and 90-day mortality in 21 359 patients following peptic ulcer bleeding - a Nationwide Cohort Study

被引:23
作者
Holland-Bill, L. [1 ,2 ]
Christiansen, C. F. [1 ]
Gammelager, H. [1 ,3 ]
Mortensen, R. N. [1 ]
Pedersen, L. [1 ]
Sorensen, H. T. [1 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark
[2] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA
[3] Aarhus Univ Hosp, Dept Anesthesiol & Intens Care Med, DK-8200 Aarhus N, Denmark
关键词
CIVIL REGISTRATION SYSTEM; 30-DAY MORTALITY; RISK-FACTORS; PREADMISSION USE; CIRRHOSIS; COMORBIDITY; PERFORATION; IMPACT; DRUGS; HOSPITALIZATION;
D O I
10.1111/apt.13073
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundBleeding is a serious and frequent complication of peptic ulcer disease. Hepatic dysfunction can cause coagulopathy and increases the risk of peptic ulcer bleeding. However, whether chronic liver disease increases mortality after peptic ulcer bleeding remains unclear. AimTo examine the prognostic impact of chronic liver disease on mortality after peptic ulcer bleeding. MethodsWe used population-based medical registries to conduct a cohort study of all Danish residents hospitalised with incident peptic ulcer bleeding from 2004 through 2011. We identified patients diagnosed with liver cirrhosis or non-cirrhotic chronic liver disease before their admission for peptic ulcer bleeding. We then computed 90-day mortality after peptic ulcer bleeding based on the Kaplan-Meier method (1 - survival function) and used a Cox regression model to estimate mortality rate ratios (MRRs), controlling for potential confounders. ResultsWe identified 21359 patients hospitalised with peptic ulcer bleeding. Among these, 653 (3.1%) had a previous diagnosis of liver cirrhosis and 474 (2.2%) had a history of non-cirrhotic chronic liver disease. Patients with liver cirrhosis and non-cirrhotic chronic liver disease had a cumulative 90-day mortality of 25.3% and 20.7%, respectively, compared to 18.3% among patients without chronic liver disease. Liver cirrhosis was associated with an adjusted 90-day MRR of 2.38 (95% CI: 2.02-2.80), compared to 1.49 (95% CI: 1.22-1.83) among patients with non-cirrhotic chronic liver disease. ConclusionPatients with chronic liver disease, particularly liver cirrhosis, are at increased risk of death within 90days after hospitalisation for peptic ulcer bleeding compared to patients without chronic liver disease.
引用
收藏
页码:564 / 572
页数:9
相关论文
共 48 条
[1]   Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time-trend analysis [J].
Ahsberg, K. ;
Ye, W. ;
Lu, Y. ;
Zheng, Z. ;
von Holstein, C. Stael .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (05) :578-584
[2]   Mortality from peptic ulcer bleeding: the impact of comorbidity and the use of drugs that promote bleeding [J].
Ahsberg, K. ;
Hoglund, P. ;
von Holstein, C. Stael .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (06) :801-810
[3]   Systematic reviews in health care - Systematic reviews of evaluations of prognostic variables [J].
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7306) :224-228
[4]  
Andersen TF, 1999, DAN MED BULL, V46, P263
[5]   Outcome of upper gastro-intestinal bleeding and use of ibuprofen versus paracetamol [J].
Blot, WJ ;
Fischer, T ;
Nielsen, GL ;
Friis, S ;
Mumma, M ;
Lipworth, L ;
DuBois, R ;
McLaughlin, JK ;
Sorensen, HT .
PHARMACY WORLD & SCIENCE, 2004, 26 (06) :319-323
[6]   BLEEDING PEPTIC-ULCER - A PROSPECTIVE EVALUATION OF RISK-FACTORS FOR REBLEEDING AND MORTALITY [J].
BRANICKI, FJ ;
COLEMAN, SY ;
FOK, PJ ;
PRITCHETT, CJ ;
FAN, ST ;
LAI, ECS ;
MOK, FPT ;
CHEUNG, WL ;
LAU, PWK ;
TUEN, HH ;
LAM, SK ;
HUI, WM ;
NG, MMT ;
LAM, DKH ;
TANG, APK ;
WONG, J .
WORLD JOURNAL OF SURGERY, 1990, 14 (02) :262-270
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]  
CHRISTENSEN E, 1981, GASTROENTEROLOGY, V81, P944
[9]   Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer [J].
Christensen, S. ;
Riis, A. ;
Norgaard, M. ;
Thomsen, R. W. ;
Sorensen, H. T. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (08) :907-912
[10]   Antipsychotic drugs and short-term mortality after peptic ulcer perforation: a population-based cohort study [J].
Christiansen, C. ;
Christensen, S. ;
Riis, A. ;
Thomsen, R. W. ;
Johnsen, S. P. ;
Tonnesen, E. ;
Sorensen, H. T. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (07) :895-902